首页> 外文OA文献 >Image cytometric DNA analysis in human breast cancer analysis may add prognostic information in diploid cases with low S-phase fraction by flow cytometry
【2h】

Image cytometric DNA analysis in human breast cancer analysis may add prognostic information in diploid cases with low S-phase fraction by flow cytometry

机译:在人乳腺癌分析中的图像细胞计数DNa分析可以通过流式细胞术在具有低s期分数的二倍体病例中添加预后信息

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Measurements of DNA ploidy can be performed either with image cytometry (ICM) or flow cytometry (FCM); both methods provide independent prognostic information in primary breast cancer. The aim of the present investigation was to compare the two methods and to relate the findings to prognosis (median follow-up 42 months). Concordance in ploidy status (diploid, tetraploid, aneuploid) was obtained in 76% of the samples (168/222). When the fraction of S-phase cells (SPF) from FCM analysis was also taken into consideration, four different groups of samples were obtained (Flow I-IV), which were considered to correspond to the Auer classification (Auer I-IV) of DNA histograms obtained from image cytometry. Complete concordance between the two techniques now was 70% (155/222). Samples classified as Flow I (diploid or near-diploid with low SPF) and Auer I had a distant metastasis rate of 3/60 (5%), as compared to 62/154 (40%) for all other combinations of the Flow and Auer classifications taken together. Thus, the only findings of prognostic importance were that some samples were Flow I but not Auer I, or vice versa. These two groups represent 17 (7.7%) and 14 (6.3%), respectively, of the total number of samples, and had frequencies of distant metastasis similar to those of the other high-risk groups, namely, 7/17 and 5/14, respectively. In a multivariate analysis, flow cytometric S-phase value was a stronger prognostic factor than either the Flow and Auer classification. We conclude that when routine FCM DNA analysis is used, diploid or near-diploid samples with a low S-phase value should be reanalyzed with ICM.
机译:DNA倍性的测量可以通过图像细胞仪(ICM)或流式细胞仪(FCM)进行;两种方法均提供了原发性乳腺癌的独立预后信息。本研究的目的是比较两种方法,并将发现与预后相关(中位随访42个月)。在76%的样品(168/222)中获得了倍性状态的一致性(二倍体,四倍体,非整倍体)。当还考虑到FCM分析得出的S期细胞分数(SPF)时,获得了四组不同的样品(流I-IV),它们被认为对应于Auer分类(Auer I-IV)。从图像细胞仪获得的DNA直方图。现在,两种技术之间的完全一致性为70%(155/222)。分类为Flow I(低SPF的二倍体或近二倍体)和Auer I的样品的远处转移率为3/60(5%),而Flow和Auer分类加在一起。因此,唯一具有预后重要性的发现是一些样品是Flow I,但不是Auer I,反之亦然。两组分别占样本总数的17(7.7%)和14(6.3%),并且远处转移的频率与其他高风险组相似,即7/17和5 / 14,分别。在多变量分析中,流式细胞术S期值是比流和Auer分类法更强的预后因素。我们得出的结论是,当使用常规FCM DNA分析时,应使用ICM重新分析S相值较低的二倍体或近二倍体样品。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号